References
- Waalen K, Duff G W, Førre ø, Dickens E, Kvarnes L, Nuki G. Inerleukin 1 activity produced by human rheumatoid and normal dendritic cells. Scand J Immunol 1986; 23: 365–71
- Wood D D, Ihrie E J, Hamerman D. Release of interleukin 1 from human synovial tissue in vitro. Arthritis Rheum 1985; 28: 853–62
- Rola-Pleszczynski M, Lemaire I. Leukotriens augment interleukin 1 production by human monocyte. J Immunol 1985; 135: 3958–61
- Dayer J M, de Rochemonteix B, Burrus B, Demczuk S, Dinarello C A. Human recombinant interleukin 1 stimulates coilagenase and prostaglandin E2 production by human synovial cells. J Clin Invest 1986; 77: 645–8
- Rooney M, Symons J A, Duff G W. Interleukin 1 beta in synovial fluid is related to local disease activity in rheumatoid arthritis. Rheumatol Int 1990; 10: 217–9
- Endres S, Cannon J G, Ghorbani R, Dempsey R A, Sisson S D, Lonnemann G, et al. In vitro production of IL-β IL-1α, TNF and IL-2 in healthy subjects: distribution, effect of cyclooxygenase inhibition and evidence of independent gene regulation. Eur J Immunol 1989; 19: 2327–33
- Vane J R. Inhibition of prostagrandin synthesis as a mechanism of action for aspirin-like drugs. Nature New Biol. 1971; 231: 232–5
- Klickstein L B, Shapleigh C, Goetzl E J. Lipoxygenation of arachidonic acid as a source of polymorphonuclear leukocyte chemotactic factors in synovial fluid and tissue in rheumatoid arthritis and spondyloarthritis. J Clin Invest 1980; 66: 1166–70
- Gerrard T L, Siegel J P, Dyer D R, Zoon K C. Differential effects of interferon-α and interferon-γ on interleukin 1 secretion by monocytes. J Immunol 1987; 138: 2535–40
- Smith D M, Johnson J A, Turner R A. Alterations in arachidonic acid metabolism and chemotactic response in polymorphonuclear leukocytes from patients with rheumatoid arthritis. Clin Exp Rheumatol 1989; 7: 471–7
- Samuelsson B. Leukotrien: Mediators of immediate hypcrsensitivity reactions and inflammation. Science, 20: 568–75
- Dinarello C A, Bishai I, Rosenwasser L J, Coceani F. The influence of lipoxygenase inhibitors on the in vitro production of human leukocytic pyrogen and lymphocyte activating factor (interleukin-1). Int Immunopharmacol 1984; 6: 43–50
- Kovacs E J, Radzioch D, Young H A, Varesio L. Differential inhibition of IL-1 and TNF-α mRNA expression by agents which block second messenger pathways in murine macrophages. J Immunol 1988; 141: 3101–5
- Knudsen P J, Dinarello C A, Strom T B. Prostagrandins posttranscriptionally inhibit monocyte expression of interleukin 1 activity by increasing intracellular cyclic adenosine monophosphate. J Immunol 1986; 137: 3189–94